Balance Sheet Dive: Cronos Group Inc (CRON)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Kevin Freeman

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

After finishing at $2.55 in the prior trading day, Cronos Group Inc (NASDAQ: CRON) closed at $2.53, down -0.78%. In other words, the price has decreased by -$0.78 from its previous closing price. On the day, 1.14 million shares were traded. CRON stock price reached its highest trading level at $2.59 during the session, while it also had its lowest trading level at $2.48.

Ratios:

Our goal is to gain a better understanding of CRON by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 23.53 and its Current Ratio is at 24.65. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of . The stock’s future direction. In the most recent recommendation for this company, Bernstein on November 02, 2022, initiated with a Mkt Perform rating and assigned the stock a target price of $3.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRON now has a Market Capitalization of 968837120 and an Enterprise Value of 184348160. As of this moment, Cronos’s Price-to-Earnings (P/E) ratio for their current fiscal year is 53.26. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.44 while its Price-to-Book (P/B) ratio in mrq is 0.90. Its current Enterprise Value per Revenue stands at 1.415 whereas that against EBITDA is -8.869.

Stock Price History:

The Beta on a monthly basis for CRON is 1.16, which has changed by 0.17129624 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, CRON has reached a high of $3.16, while it has fallen to a 52-week low of $1.60. The 50-Day Moving Average of the stock is -0.87%, while the 200-Day Moving Average is calculated to be 21.04%.

Shares Statistics:

The stock has traded on average 2.82M shares per day over the past 3-months and 2324830 shares per day over the last 10 days, according to various share statistics. A total of 383.81M shares are outstanding, with a floating share count of 197.90M. Insiders hold about 48.32% of the company’s shares, while institutions hold 13.77% stake in the company. Shares short for CRON as of 1759190400 were 3228634 with a Short Ratio of 1.14, compared to 1756425600 on 2599043. Therefore, it implies a Short% of Shares Outstanding of 3228634 and a Short% of Float of 1.63.

Earnings Estimates

. The current assessment of Cronos Group Inc (CRON) involves the perspectives of 1.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.0, with high estimates of $0.0 and low estimates of $0.0.

Analysts are recommending an EPS of between $0.07 and -$0.11 for the fiscal current year, implying an average EPS of -$0.02. EPS for the following year is $0.1, with 2.0 analysts recommending between $0.11 and $0.08.

Revenue Estimates

1 analysts predict $51.31M in revenue for . The current quarter. It ranges from a high estimate of $51.31M to a low estimate of $51.31M. As of . The current estimate, Cronos Group Inc’s year-ago sales were $47.69MFor the next quarter, 1 analysts are estimating revenue of $61.5M. There is a high estimate of $61.5M for the next quarter, whereas the lowest estimate is $61.5M.

A total of 3 analysts have provided revenue estimates for CRON’s current fiscal year. The highest revenue estimate was $203.2M, while the lowest revenue estimate was $176.1M, resulting in an average revenue estimate of $192.91M. In the same quarter a year ago, actual revenue was $169.71MBased on 2 analysts’ estimates, the company’s revenue will be $248.05M in the next fiscal year. The high estimate is $303.49M and the low estimate is $192.6M.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.